Search Results 131-140 of 11169 for Lovastatin

  1. Lutetium lu 177 dotatate (intravenous route) - Mayo Clinic

    Lutetium Lu 177 dotatate injection is used to treat somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including tumors of ...

  2. Rivastigmine (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Capsule. Back to top ...

  3. Drugs and Supplements that Start with X - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “X” to learn about drug side effects, proper use and ...

  4. Larotrectinib (oral route) - Side effects & dosage - Mayo Clinic

    Your doctor will perform a test to make sure this medicine is right for you. Larotrectinib belongs to the group of medicines called antineoplastics (cancer ...

  5. Anti-Lag-3 (Relatlimab) And Anti-PD-1 Blockade (Nivolumab) Versus Standard Of Care (Lomustine) For The Treatment Of Patients With Recurrent Glioblastoma - Mayo Clinic

    Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's deoxyribonucleic acid (DNA) and may kill cancer ...

  6. Ritonavir (oral route) - Side effects & dosage - Mayo Clinic

    ... lovastatin (Altocor®, Mevacor®), lurasidone (Latuda®), oral midazolam (Versed®), pimozide (Orap®), propafenone (Rythmol®), quinidine (Quinaglute ...

  7. Metastatic Prostate Cancer Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine if salvage stereotactic body radiotherapy (SBRT) is non-inferior to moderately hypofractionated radiation therapy ( ...

  8. Bicalutamide (oral route) - Mayo Clinic

    Bicalutamide is used together with a luteinizing hormone releasing hormone (LHRH) analog (eg, goserelin or leuprolide) to treat stage D2 metastatic prostate ...

  9. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  10. A Study To Evaluate The Combination Of Binimetinib And Palbociclib In Treating Patients With KRAS And NRAS Mutant Metastatic Or Unresectable Colorectal Cancer - Mayo Clinic

    The purose of this study is to determine how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive ...